Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03607968
Other study ID # 201604022RIND
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2011
Est. completion date December 31, 2015

Study information

Verified date May 2016
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background/Purpose:

A novel transvaginal mesh (TVM) surgery for women with pelvic organ prolapse (POP) had been reported. However, factors affecting the efficacy of this novel TVM surgery are unknown; and the above information should be important for preoperative consultation, especially for POP women with concomitant urodynamic stress incontinence (USI). Thus, the aim of this study is to investigate the factors responsible for anti-incontinence effect of this novel anterior TVM surgery.

Patients and Methods:

All women with POP and concomitant overt or occult USI, who underwent the novel anterior TVM surgeries, were enrolled in this study. Medical records, including urodynamic studies, questionnaires and 3-day bladder diaries, were retrospectively reviewed. Linear regress analysis was used to identify factors that were responsible for the changes in pad weights from baseline [i.e., 100 * (postoperative pad weight - baseline pad weight)/baseline pad weight].

Expected Results:

The investigators will get the factors responsible for anti-incontinence effect of this novel anterior TVM surgery. Key Words: pelvic organ prolapse, stress urinary incontinence, pad test, urodynamic stress incontinence


Description:

Background/Purpose:

A novel transvaginal mesh (TVM) surgery for women with pelvic organ prolapse (POP) had been reported. However, factors affecting the efficacy of this novel TVM surgery are unknown; and the above information should be important for preoperative consultation, especially for POP women with concomitant urodynamic stress incontinence (USI). Thus, the aim of this study is to investigate the factors responsible for anti-incontinence effect of this novel anterior TVM surgery.

Methods:

All women with POP and concomitant overt or occult USI, who underwent the novel anterior TVM surgeries between November 2011 and December 2015 at the Department of Obstetrics & Gynecology, were enrolled in this study. Medical records, including urodynamic studies, questionnaires and 3-day bladder diaries, were retrospectively reviewed. Linear regress analysis was used to identify factors that were responsible for the changes in pad weights from baseline [i.e., 100 * (postoperative pad weight - baseline pad weight)/baseline pad weight].

Expected Results:

The investigators will get the factors responsible for anti-incontinence effect of this novel anterior TVM surgery.


Recruitment information / eligibility

Status Completed
Enrollment 134
Est. completion date December 31, 2015
Est. primary completion date December 31, 2015
Accepts healthy volunteers No
Gender Female
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Female

- Diagnosed with pelvic organ prolapse and concomitant overt or occult urodynamic stress incontinence

- Received the novel anterior transvaginal mesh surgery.

Exclusion Criteria:

- Pregnant women, prepare for pregnancy or younger than 20-year-old

- Significant severe urinary urgency

- Mixed urinary incontinence with dominant urgency incontinence

- Regular urethral catheterization or intermittent self-catheterization

- Urinary tract infection (UTI) or chronic inflammation in recent 2 weeks before operation

- Bladder calculus

- A history of pelvic radiotherapy

- Preexisting malignant pelvic tumors.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
The novel anterior TVM surgeries
A novel transvaginal mesh (TVM) surgery fro women with pelvic organ prolapse (POP) had been reported. Chang TC, Hsiao SM, Chen CH, Wu WY, Lin HH. Clinical outcomes and urodynamic effects of tailored transvaginal mesh surgery for pelvic organ prolapse. Biomed Res Int http;//dx.doi.org/10.1155/2015/191258.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Improvement of urodynamic stress incontinence Preoperative and postoperative urodynamic studies to detect USI 2011/11/01-2015/12/31
Secondary Improvement of stress urinary incontinence Preoperative and postoperative 20-minute pad test changes 2011/11/01-2015/12/31